The role of homocysteine as a significant risk factor for white matter lesions in Japanese women with rheumatoid arthritis

Metabolism: Clinical and Experimental

Volumn 58, Issue 1, 2009, Pages 69-73

  Anan, Futoshi ^a   Masaki, Takayuki ^b   Tatsukawa, Hiroshi ^a   Nagano, Shuji ^a   Oribe, Motohiro ^c   Eshima, Nobuoki ^d   Saikawa, Tetsunori ^d   Yoshimatsu, Hironobu ^b  

^a OITA RED CROSS HOSPITAL   (Japan)

^b OITA UNIVERSITY   (Japan)

^c Oribe Rheumatism and Internal Medicine Clinic   (Japan)

^d OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BRAIN DAMAGE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; JAPAN; METABOLIC PARAMETERS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; WHITE MATTER LESION;

ARTHRITIS, RHEUMATOID; BLOOD GLUCOSE; BLOOD PRESSURE; BRAIN DISEASES; CHOLESTEROL; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FEMALE; HEART RATE; HOMOCYSTEINE; HUMANS; JAPAN; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MULTIVARIATE ANALYSIS; STROKE; TRIGLYCERIDES;

EID: 57049114957     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.08.008     Document Type: Article

References (40)

1. Solomon D.H., Karlson E.W., Rimm E.B., et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 107 (2003) 1303-1307
2. Maradit-Kremers H., Crowson C., Nicola P., et al. Increased unrecognized coronary heart disease and sudden death in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 52 (2005) 402-411
3. Ramos M., and Mandybur T.I. Cerebral vasculitis in rheumatoid arthritis. Arch Neurol 32 (1975) 271-275
4. Awad I.A., Johnson P.C., Spetzler R.F., et al. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I:correlation with age and cerebrovascular risk factors. Stroke 17 (1986) 1084-1089
5. Bots M.L., van Swieten J.C., Breteler M.M., et al. Cerebral white matter lesions and atherosclerosis in the Rotterdam Study. Lancet 341 (1993) 1232-1237
6. Pantoni L., and Garcia J.H. Pathogenesis of leukoaraiosis. Stroke 28 (1997) 652-659
7. Dufouil C., de Kersaint-Gilly A., Besancon V., et al. Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort. Neurology 56 (2001) 921-926
8. Perros P., Deary I.J., Sellar R.J., et al. Brain abnormalities demonstrated by magnetic resonance imaging in adult IDDM patients with and without a history of recurrent severe hypoglycemia. Diabetes Care 20 (1997) 1013-1018
9. Wong T.Y., Klein R., Sharrett A.R., et al. Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA 288 (2002) 67-74
10. Vermeer S.E., Hollander M., van Dijk E.J., et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 34 (2003) 1126-1129
11. Longstreth Jr. W.T., Manolio T.A., and Arnold A. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 27 (1996) 1274-1282
12. Schmidt R., Launer L.J., and Nilsson L.G. CASCADE Consortium. A magnetic resonance imaging of midlife blood pressure to late-life cognitive decline and brain morphology. Diabetes 53 (2004) 687-692
13. The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288 (2002) 2015-2022
14. Wald D.S., Law M., and Morris J.K. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325 (2002) 1202-1206
15. Vermeer S.E., van Dijk E.J., and Koudstaal P.J. Homocysteine, silent brain infarcts, and white matter lesions: the Rotterdam Scan Study. Ann Neurol 51 (2002) 285-289
16. Wright C.B., Paik M.C., and Brown T.R. Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study. Stroke 36 (2005) 1207-1211
17. Dufouil C., Alpérovitch A., Ducros V., et al. Homocysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann Neurol 3 (2003) 214-221
18. Arnett F., Edworthy S.M., Bloch D.A., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 (1988) 315-324
19. Friedwald W.T., Levi R.I., and Fredrickson D.C. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the ultracentrifuge. Clin Chem 18 (1972) 499-502
20. Chonbanian A.V., Bakris G.L., Black H.R., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42 (2003) 1206-1252
21. Liao D., Sloan R.P., CaWMLo W.E., et al. Multiple metabolic syndrome is associated with lower heart rate variability. The Atherosclerosis Risk in Communities Study. Diabetes Care 21 (1998) 2116-2122
22. Donnelly J.G., and Pronovost C. Evaluation of the Abbott IMx fluorescence polarization immunoassay and the Bio-Rad enzyme immunoassay for homocysteine: comparison with high-performance liquid chromatography. Ann Clin Biochem 37 (2000) 194-198
23. Breteler M.M., van Swieten J.C., Bots M.L., et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 44 (1994) 1246-1252
24. Shimada K., Kawamoto A., and Matsubayashi K. Silent cerebrovascular disease in the elderly. Correlation with ambulatory pressure. Hypertension 16 (1990) 692-699
25. Sierra C., de la Sierra A., and Mercader J. Silent cerebral white matter lesions in middle-aged essential hypertensive patients. J Hypertens 20 (2002) 519-524
26. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
27. Libby P., and Ridker P.M. Novel inflammatory markers of coronary risk: theory versus practice. Circulation 100 (1999) 1148-1150
28. Vaudo G., Marchesi S., Gerli R., et al. Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis 63 (2004) 31-35
29. van Dijk E.J., Prins N.D., Vermeer S.E., et al. C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation 112 (2005) 900-905
30. Okamura T., Kitamura A., and Moriyama Y. Plasma level of homocysteine is correlated to extracranial carotid-artery atherosclerosis in non-hypertensive Japanese. J Cardiovasc Risk 6 (1999) 371-377
31. Stamler J.S., Osborne J.A., Jaraki O., et al. Adverse vascular effects of homocysteine are modulated of nitrogen endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 91 (1993) 308-318
32. Dardik R., Varon D., and Tamarin I. Homocysteine and oxidized low density enhanced platelet adhesion to endothelial cells under flow conditions: distinct mechanisms of thrombogenic modulation. Thromb Haemost 83 (2000) 338-344
33. Tsai J.C., Perrella M.A., Yoshizumi M., et al. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA 91 (1994) 6369-6373
34. Schreiner P.J., Wu K.K., Malinow M.R., et al. Hyperhomocyst(e)inemia and hemostatic factors: the atherosclerosis risk in communities study. Ann Epidemiol 12 (2002) 228-236
35. Hassan A., Hunt B.J., and O'Sullivan M. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain 127 (2004) 212-219
36. Shimomura T., Anan F., Umeno Y., et al. Hyperhomocysteinemia is a significant risk factor for white matter lesions in Japanese type 2 diabetic patients. Eur J Neurol 15 (2008) 289-294
37. La Montagna G., Cacciapuoti F., Biono R., et al. Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis. Diab Vacular Dis Res 4 (2007) 130-135
38. Moriyama Y., Okamura T., and Kajinami K. Effects of serum B vitamins on elevated plasma homocysteine levels associated with the mutation of methylenetetrahydrofolate reductase gene in Japanese. Atherosclerosis 164 (2002) 321-328
39. Arai R., Maruyama C., Igarashi S., et al. Effects of short-term folic acid and/or riboflavin supplementation on serum folate and plasma total homocysteine concentrations in young Japanese male subjects. Eur J Clin Nutr 60 (2006) 573-579
40. Davies L., Wilmshurst E.G., Mcelduff A., et al. The relationship among homocysteine, creatinine clearance, and albuminuria in patients with type 2 diabetes. Diabetes Care 24 (2001) 1805-1809